Effect of a high-fructose weight-maintaining diet on lipogenesis and liver fat

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 6, 2015, Pages 2434-2442

  Schwarz, Jean Marc ^a,b,c   Noworolski, Susan M ^b   Wen, Michael J ^c   Dyachenko, Artem ^a   Prior, Jessica L ^a   Weinberg, Melissa E ^b,c   Herraiz, Laurie A ^d   Tai, Viva W ^c,d   Bergeron, Nathalie ^a   Bersot, Thomas P ^b,e   Rao, Madhu N ^b,c   Schambelan, Morris ^b,c   Mulligan, Kathleen ^b,c  

^a TOURO UNIVERSITY CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

^d UCSF Clinical and Translational Science Institute Clinical Research Center   (United States)

^e GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE; GLUCOSE; INSULIN; CARBOHYDRATE DIET;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CARBOHYDRATE DIET; CARBOHYDRATE INTAKE; CONTROLLED STUDY; DIET RESTRICTION; GLUCONEOGENESIS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; HUMAN; HUMAN EXPERIMENT; INSULIN SENSITIVITY; LIPID METABOLISM; LIPOGENESIS; LIVER FAT; MACRONUTRIENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; ADIPOSE TISSUE; ADOLESCENT; AGED; CLINICAL TRIAL; DRUG EFFECTS; LIVER; METABOLISM; MIDDLE AGED; OBESITY; PHARMACOLOGY; YOUNG ADULT;

ADIPOSE TISSUE; ADIPOSITY; ADOLESCENT; ADULT; AGED; BODY WEIGHT; DIETARY CARBOHYDRATES; FRUCTOSE; GLUCOSE; HUMANS; LIPID METABOLISM; LIPOGENESIS; LIVER; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84930809200     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-3678     Document Type: Article

References (39)

1. Swinburn BA, Sacks G, Hall KD, et al. The global obesity pandemic: Shaped by global drivers and local environments. Lancet. 2011;378(9793):804-814.
2. Lam DW, LeRoith D. The worldwide diabetes epidemic. Curr Opin Endocrinol Diabetes Obes. 2012;19(2):93-96.
3. Schattenberg JM, Schuppan D. Nonalcoholic steatohepatitis: The therapeutic challenge of a global epidemic. Curr Opin Lipidol. 2011;22(6):479-488.
4. Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr. 2004;79(4):537-543.
5. Lim JS, Mietus-Snyder M, Valente A, Schwarz JM, Lustig RH. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol. 2010;7(5):251-264.
6. Te Morenga L, Mallard S, Mann J. Dietary sugars and body weight: Systematic review and meta-analyses of randomised controlled trials and cohort studies. BMJ. 2012;346:e7492.
7. Bantle JP, Raatz SK, Thomas W, Georgopoulos A. Effects of dietary fructose on plasma lipids in healthy subjects. Am J Clin Nutr. 2000;72(5):1128-1134.
8. Teff KL, Elliott SS, Tschöp M, et al. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab. 2004;89(6):2963-2972.
9. Chong MF, Fielding BA, Frayn KN. Mechanisms for the acute effect of fructose on postprandial lipemia. Am J Clin Nutr. 2007;85(6):1511-1520.
10. Stanhope KL, Schwarz JM, Keim NL, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest. 2009;119(5):1322-1334.
11. Lê KA, Ith M, Kreis R, et al. Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr. 2009;89(6):1760-1765.
12. Hudgins LC, Parker TS, Levine DM, Hellerstein MK. A dual sugar challenge test for lipogenic sensitivity to dietary fructose. J Clin Endocrinol Metab. 2011;96(3):861-868.
13. Kannel WB, Vasan RS. Triglycerides as vascular risk factors: New epidemiologic insights. Curr Opin Cardiol. 2009;24(4):345-350.
14. Basu S, Yoffe P, Hills N, Lustig RH. The relationship of sugar to population-level diabetes prevalence: An econometric analysis of repeated cross-sectional data. PloS One. 2013;8(2):e57873.
15. Romaguera D, Norat T, Wark PA, et al. Consumption of sweet beverages and type 2 diabetes incidence in European adults: Results from EPIC-InterAct. Diabetologia. 2013;56(7):1520-1530.
16. Maersk M, Belza A, Stødkilde-Jørgensen H, et al. Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: A 6-mo randomized intervention study. Am J Clin Nutr. 2012;95(2):283-289.
17. Zivkovic AM, German JB, Sanyal AJ. Comparative review of diets for the metabolic syndrome: Implications for nonalcoholic fatty liver disease. Am J Clin Nutr. 2007;86(2):285-300.
18. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications. Hepatology. 2010;51(2):679-689.
19. Targher G, Marra F, Marchesini G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: Causal effect or epiphenomenon? Diabetologia. 2008;51(11):1947-1953.
20. Samuel VT. Fructose induced lipogenesis: From sugar to fat to insulin resistance. Trends Endocrinol Metab. 2011;22(2):60-65 .
21. Bazzano LA, Hu T, Reynolds K, et al. Effects of Low-Carbohydrate and Low-Fat Diets: A Randomized Trial. Ann Intern Med. 2014;161:309-318.
22. de Ruyter JC, Olthof MR, Seidell JC, Katan MB. A trial of sugar-free or sugar-sweetened beverages and body weight in children. New Engl J Med. 2012;367(15):1397-1406.
23. Ebbeling CB, Feldman HA, Chomitz VR, et al. A randomized trial of sugar-sweetened beverages and adolescent body weight. New Engl J Med. 2012;367(15):1407-1416.
24. Page KA, Chan, O, Arora J, et al. Effects of fructose vs glucose on regional cerebral blood flow in brain regions involved with appetite and reward pathways. JAMA. 2013;309(1):63-70.
25. Johnson RK, Appel LJ, Brands M, et al. Dietary sugars intake and cardiovascular health: A scientific statement from the American Heart Association. Circulation. 2009;120(11):1011-1020.
26. Wang DD, Sievenpiper JL, de Souza RJ, et al. Effect of fructose on postprandial triglycerides: A systematic review and meta-analysis of controlled feeding trials. Atherosclerosis. 2014;232:125-133.
27. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214-E223.
28. Ferrannini E. The theoretical bases of indirect calorimetry: A review. Metabolism. 1988;37(3):287-301.
29. Noworolski SM, Tien PC, Merriman R, Vigneron DB, Qayyum A. Respiratory motion-corrected proton magnetic resonance spectroscopy of the liver. Magn Reson Imaging. 2009;27(4):570-576.
30. Hellerstein MK, Neese RA. Mass isotopomer distribution analysis at eight years: Theoretical, analytic, and experimental considerations. Am J Physiol. 1999;276(6 Pt 1):E1146-E1170.
31. Schwarz JM, Neese RA, Turner S, Dare D, Hellerstein MK. Shortterm alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection. J Clin Invest. 1995;96(6):2735-43.
32. Aeberli I, Hochuli M, Gerber PA, et al. Moderate amounts of fructose consumption impair insulin sensitivity in healthy young men: A randomized controlled trial. Diabetes Care. 2013;36(1):150-156.
33. Schwarz JM, Linfoot P, Dare D, Aghajanian K. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr. 2003;77(1):43-50.
34. Sobrecases H, Lê KA, Bortolotti M, et al. Effects of short-term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men. Diabetes Metab. 2010;36(3):244-246.
35. Tappy L, Lê KA. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev. 2010;90(1):23-46.
36. Ngo Sock ET, Lê KA, Ith M, Kreis R, Boesch C, Tappy L. Effects of a short-term overfeeding with fructose or glucose in healthy young males. Br J Nutr. 2010;103(7):939-943.
37. Silbernagel G, Machann J, Unmuth S, et al. Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial. Br J Nutr. 2011;106(1):79-86.
38. McGarry JD. Banting lecture 2001: Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes. 2002;51(1):7-18.
39. Marriott BP, Cole N, Lee E. National estimates of dietary fructose intake increased from 1977 to 2004 in the United States. J Nutr. 2009;139(6):1228S-1235S.